Figure 3.
(A) 5-year CSSs in all patients between lymph node count ≥9 and <9. (B) 5-year CSSs in patients with stage I between lymph node count ≥9 and <9. (C) 5-year CSSs in patients with stage II between lymph node count ≥9 and <9. (D) 5-year CSSs in patients with stage III between lymph node count ≥9 and <9.